The Drug Tariff Preface published monthly, lists additions, deletions and other changes to products listed in the Drug Tariff. Below is a summary of the changes coming into effect from 1 October 2024. Key g Special container – This product is a special container and should be dispensed in its complete original pack size. n Item requiring reconstitution [...]
The post Drug Tariff Watch – October 2024 appeared first on Community Pharmacy England.
The Drug Tariff Preface published monthly, lists additions, deletions and other changes to products listed in the Drug Tariff. Below is a summary of the changes coming into effect from 1 September 2024. Key g Special container – This product is a special container and should be dispensed in its complete original pack size. n Item requiring reconstitution [...]
The post Drug Tariff Watch – September 2024 appeared first on Community Pharmacy England.
Following representations from Community Pharmacy England, the Department of Health and Social Care (DHSC) has confirmed that the following products have been granted upward retrospective pricing adjustments due to out of date product and/or pricing information held on NHS dictionary of medicines and devices (dm+d). A change to the reimbursement will apply to prescriptions dispensed [...]
The post Retrospective pricing adjustments for Aptamil products appeared first on Community Pharmacy England.
Class 4 Medicines Defect Information: Omeprazole products (Sandoz Limited) Drug alert number: EL (24)A/34 Date issued: 07 August 2024 The Medicines and Health products Regulatory Agency (MHRA) has issued a class 4 medicines defect information notice for: Omeprazole products (Sandoz Limited) Company name: Sandoz Limited Product name: Omeprazole 10mg gastro-resistant capsules, PL 04416/0651 SNOMED Code: 3753411000001102 [...]
The post MHRA Class 4 Medicines Defect Information: Omeprazole products (Sandoz Limited) appeared first on Community Pharmacy England.
MSD UK in agreement with the Medicines and Healthcare product Regulatory Agency (MHRA) has announced an extension to the shelf-life of of certain batches of Lagevrio® (molnupiravir) 200 mg hard capsules beyond the labelled expiry date by 6, 12 or 18 months. This extension is based on supportive stability data for Lagevrio® which has been [...]
The post Lagevrio® (molnupiravir) 200 mg hard capsules – shelf life extension appeared first on Community Pharmacy England.
Recent Comments